Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
This dual-peptide blend combines two research bioactive sequences: BPC-157, a gastric-derived synthetic peptide fragment, and TB-500 (Thymosin Beta-4 fragment), a stabilized actin-binding regulator analogue
It produces a biased signaling pattern that favors cAMP generation over beta-arrestin recruitment at the GLP-1 receptor, which may enhance insulin response while reducing some side effects associated with traditional GLP-1 agonists
mellonella and murine infection models
Through these receptors, GLP-1 helps regulate blood glucose, appetite, and body weight
Secondly, because tirzepatide is prescribed alongside lifestyle modifications including dietary changes, the quality and composition of food intake directly influences treatment outcomes
.jpg)